Terumo (4543) · InitiativeAdvanced
Terumo Ventures' Investment in Medical Device Startups
First written in FY2025. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Corporate venture capital business through the establishment of S VenturesA theme 34 companies write about · 0 as a headwind · 34 as a tailwind
15 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 34 companies compared. The sentences above are computed from all 34.Full recordFilings, disclosures and news, newest first
- FY2026AdvancedAnnual report
「Terumo Ventures, the Company's CVC division, is also steadily expanding its investments in medtech companies, primarily in the United States.」
Terumo Ventures expanded its investments in medtech companies, primarily in the United States, as a CVC with a $75 million investment allocation over 5 years. - FY2025First statedAnnual report
「The Company established Terumo Ventures, a corporate venture capital (CVC) division, in the United States to accelerate innovation through stronger collaboration with medical device start-ups. It began investing in companies in areas including cardiovascular disease treatment, chronic disease treatment and digital technologies, with an investment allocation of $75 million over the next 5 years.」
The CVC established in August 2024 was developed into a start-up collaboration and investment platform with an investment allocation of $75 million over the next 5 years.